| Breakdown | TTM | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 38.53B | 42.01B | 39.21B | 37.70B | 35.27B | 26.59B |
| Gross Profit | 16.97B | 17.73B | 17.17B | 16.22B | 14.03B | 10.26B |
| EBITDA | 6.55B | 6.68B | 6.78B | 6.15B | 4.18B | 2.22B |
| Net Income | 3.59B | 3.90B | 3.89B | 3.68B | 2.74B | 1.49B |
Balance Sheet | ||||||
| Total Assets | 48.35B | 54.41B | 49.24B | 44.57B | 40.21B | 36.65B |
| Cash, Cash Equivalents and Short-Term Investments | 14.40B | 11.12B | 15.78B | 13.59B | 11.44B | 10.00B |
| Total Debt | 1.15B | 1.74B | 1.42B | 1.63B | 1.94B | 2.07B |
| Total Liabilities | 10.12B | 11.34B | 10.53B | 8.69B | 8.83B | 8.27B |
| Stockholders Equity | 38.24B | 43.06B | 38.72B | 35.88B | 31.38B | 28.38B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | -3.47B | 4.04B | 3.51B | 2.33B | 2.63B |
| Operating Cash Flow | 0.00 | 4.52B | 5.75B | 4.59B | 3.09B | 3.65B |
| Investing Cash Flow | 0.00 | -8.47B | -2.00B | -1.46B | -1.11B | -748.29M |
| Financing Cash Flow | 0.00 | -1.05B | -1.37B | -1.37B | -677.42M | -565.67M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
81 Outperform | ¥108.16B | 136.93 | 5.02% | 3.23% | -30.60% | -84.58% | |
79 Outperform | ¥137.12B | 9.64 | ― | 3.24% | 8.95% | 18.54% | |
78 Outperform | ¥41.98B | 9.99 | 9.42% | 3.31% | 7.14% | -0.06% | |
72 Outperform | ¥85.64B | 19.88 | ― | 2.16% | -3.65% | -47.21% | |
71 Outperform | ¥97.27B | 11.87 | 9.39% | 1.68% | 7.26% | 28.36% | |
63 Neutral | $10.79B | 15.43 | 7.44% | 2.01% | 2.89% | -14.66% | |
59 Neutral | ¥12.41B | 22.02 | ― | 2.71% | 1.90% | -54.49% |